A woman in her 60s had been losing weight and had bowel symptoms when a gastroenterologist spotted a “pelvic mass” on her uterus, following a CT colonograp ...

A panelist discusses how education and cost are key challenges in ensuring comprehensive molecular testing is performed in a ...

A panelist discusses how multiple molecular biomarkers beyond BRCA and homologous recombination deficiency (HRD) testing are ...

The FDA has granted fast track designation to INX-315 for the treatment of CCNE1-amplified, platinum-resistant/refractory ovarian cancer.